MedPath

Impact of Another Person's Presence on Brain and Behavioral Performance

Not Applicable
Terminated
Conditions
Behavior and Behavior Mechanisms
Registration Number
NCT03453216
Lead Sponsor
Hôpital le Vinatier
Brief Summary

In a recent study, investigators provided the first neuroscientific data on social facilitation. This neuroimaging study, performed in the macaque monkey, shows a marked improvement in performance in a simple task when a congener is present compared to when the animal performs the task alone. This social facilitation is accompanied by a significant increase in brain activity within the fronto-parietal network of attention. No variation in activity, however, is observed in the cerebral network of motivation. These results argue in favor of the implication of attentional processes in the phenomenon of social facilitation. The challenge now is to determine whether social facilitation is always based on the attention network (whatever the task) or, alternatively, whether it increases activity in any cerebral circuit involved depending on the task performed and the population studied. This hypothesis, which the investigators have named the "multi-mediator model of social facilitation", has the advantage of reconciling the attentional and motivational theories of social facilitation, which are not mutually exclusive. This hypothesis also provides an explanation for the pervasiveness (across species and different ages for humans) of social facilitation. The main objective of SOFEE is to gather neuroscientific evidence to support the multi-facilitator model of social facilitation.

Detailed Description

The main objective is to study the effect of the presence of others on cognitive performance and its evolution during development by behavioral and neural measures. The secondary objective is to identify factors (psychological characteristics such as personality traits) explaining individual, behavioral and neural differences, sensitivity to the presence of others.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
112
Inclusion Criteria
  • Girl or boy aged ≥ 8 years and ≤ 12 years old for children,
  • Girl or boy aged ≥ 13 years and ≤ 19 years old for teenagers,
  • Woman or man age ≥ 20 years and ≤ 35 years old for young adults,
  • French mother tongue,
  • With the right to a social security scheme or similar,
  • With informed consent form signed by the legal representatives and the subject, for minors,
  • Has signed the informed consent form, for adults.
Exclusion Criteria
  • Known acquired neurological disorders, including epilepsy,
  • Known psychiatric disorders,
  • Complications at birth requiring admission to neonatal intensive care unit,
  • Ongoing treatment with drugs affecting the central nervous system,
  • Significant hearing impairment,
  • Uncorrected visual inadequacy,
  • Left manual preference,
  • Contraindications to the MRI examination (people using a pacemaker or an insulin pump, people wearing a metal prosthesis or an intracerebral clip as well as claustrophobic subjects),
  • Refusal of the subject or parents of the subject to be informed of any anomalies detected on the MRI,
  • Pregnancy for women of childbearing age: the possibility of pregnancy will be ruled out on questioning for inclusion,
  • Protected persons other than children

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Behavioral performance evaluationan average of 5 years

percentage of correct answers and reaction time when performing cognitive number and rhyme comparison tasks in the presence or absence of a familiar peer

identification through Functional Magnetic Resonance Imaging (fMRI ) of brain activity related to the presence of othersan average of 5 years

Comparison of activity in the three populations tested (children, adolescents, adults)

Secondary Outcome Measures
NameTimeMethod
Determination of individual characteristicsan average of 5 years

answers of self-assessment questionnaires and semi-directive interview

Trial Locations

Locations (1)

CH Le Vinatier

🇫🇷

BRON Cedex, Rhône-Alpes, France

CH Le Vinatier
🇫🇷BRON Cedex, Rhône-Alpes, France
POISSON ALICE, PH
Contact
0437915163
alice.poisson@ch-le-vinatier.fr
VIAL VERONIQUE
Contact
0437915531
veronique.vial@ch-le-vinatier.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.